2-Bromo-alpha-ergocryptine

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID2786
Ligand Name2-Bromo-alpha-ergocryptine
PubMed Compound Id31101
StructureProduct Image
Molecular FormulaC32H40BrN5O5
Molecular Weight654.6
SMILESCC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
Synonymsbromocriptine
Bromocryptine
Bromocriptin
Bromoergocryptine
Bromergocryptine
Bromoergocriptine
2-Bromo-alpha-ergocryptine
Bromocriptina
Bromocriptinum
2-Bromo-alpha-ergokryptine
Ergoset
2-Bromo-alpha-ergokryptin
Ergocryptine, 2-bromo-
Bromocriptinum [INN-Latin]
Bromocriptina [INN-Spanish]
2-Bromoergocryptine
CCRIS 3244
EINECS 247-128-5
UNII-3A64E3G5ZO
3A64E3G5ZO
CHEBI:3181
DTXSID1022687
SANDOZ 15-754
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
DTXCID602687
Bromocryptin
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
2-Bromoergokryptine
2 Bromo alpha ergocryptine
Bromocriptinum (INN-Latin)
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
Bromocriptina (INN-Spanish)
2 Bromoergocryptine
2 Bromoergokryptine
2 Bromo alpha ergokryptine
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
G02CB01
N04BC01
247-128-5
25614-03-3
CB-154
Bromocriptine (mesylate)
(+)-Bromocriptine
CB 154
22260-51-1
(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-
2-Bromo-.alpha.-ergocryptine
NSC169774
Bromocriptine (USAN/INN)
Bromokryptine
SR-01000075356
Bromocriptine [USAN:INN:BAN]
NCGC00024584-03
08Y
Bromocriptine+ (GTP-)
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
BROMOCRIPTINE [MI]
Biomol-NT_000005
CHEMBL493
GTPL35
BROMOCRIPTINE [INN]
BROMOCRIPTINE [USAN]
Lopac0_000171
SCHEMBL25297
BROMOCRIPTINE [VANDF]
BIDD:GT0464
SPBio_002101
BROMOCRIPTINE [WHO-DD]
BPBio1_001131
BDBM81993
Tox21_110907
PDSP2_001500
AKOS015961273
CCG-204266
DB01200
SDCCGSBI-0050159.P003
NCGC00024584-04
NCGC00024584-05
NCGC00024584-07
NCGC00024584-09
NCGC00024584-17
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
AC-13601
AC-37665
DA-61890
NCI60_001365
CAS-25614-03-3
NS00001292
C06856
D03165
EN300-19768234
Q413581
SR-01000075356-5
BRD-K14496212-001-01-1
BRD-K14496212-066-02-2
BRD-K14496212-066-04-8
SAN 15-754; Sandoz 15-754; -Bromocryptine; -Bromoergocryptine; -Ergolactin
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(5alpha,5'beta)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm